{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:25:27Z","timestamp":1790774727311,"version":"4.1.0"},"reference-count":139,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/mbc.0b013e32834cb35d","type":"journal-article","created":{"date-parts":[[2011,11,16]],"date-time":"2011-11-16T00:24:31Z","timestamp":1321403071000},"page":"11-22","source":"Crossref","is-referenced-by-count":67,"title":["Structure and function of von Willebrand factor"],"prefix":"10.1097","volume":"23","author":[{"given":"Md. Imtaiyaz","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faizan","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210203","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1182\/blood-2002-10-3093","article-title":"Cell type-specific regulation of von Willebrand factor expression by the E4BP4 transcriptional repressor.","volume":"105","author":"Hough","year":"2005","journal-title":"Blood"},{"key":"R2-2-20210203","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1182\/blood-2009-07-235101","article-title":"Amino acid residues Arg(659), Arg(660), and Tyr(661) in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor.","volume":"115","author":"Jin","year":"2010","journal-title":"Blood"},{"key":"R3-2-20210203","first-page":"475","article-title":"Domain structure of human von Willebrand factor, and its modulators involved in the platelet adhesion process in vitro.","volume":"32","author":"Fujimura","year":"1991","journal-title":"Rinsho Ketsueki"},{"key":"R5-2-20210203","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-0038-1646168","article-title":"von Willebrand factor: structure and function.","volume":"70","author":"Meyer","year":"1993","journal-title":"Thromb Haemost"},{"key":"R6-2-20210203","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0268-960X(02)00017-6","article-title":"Control of von Willebrand factor multimer size and implications for disease.","volume":"16","author":"Pimanda","year":"2002","journal-title":"Blood Rev"},{"issue":"Suppl 5","key":"R7-2-20210203","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2516.2008.01848.x","article-title":"Function of von Willebrand factor in haemostasis and thrombosis.","volume":"14","author":"Reininger","year":"2008","journal-title":"Haemophilia"},{"key":"R8-2-20210203","first-page":"857","article-title":"Injury induces increase of von Willebrand factor in rat endothelial cells.","volume":"134","author":"Reidy","year":"1989","journal-title":"Am J Pathol"},{"key":"R9-2-20210203","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1538-7836.2009.03653.x","article-title":"The glycoprotein Ibalpha-von Willebrand factor interaction induces platelet apoptosis.","volume":"8","author":"Li","year":"2010","journal-title":"J Thromb Haemost"},{"key":"R10-2-20210203","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1182\/blood.V83.12.3536.3536","article-title":"von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies.","volume":"83","author":"Vischer","year":"1994","journal-title":"Blood"},{"key":"R11-2-20210203","doi-asserted-by":"crossref","first-page":"28596","DOI":"10.1074\/jbc.M110.131227","article-title":"Factor VIII and platelets synergistically accelerate cleavage of von Willebrand factor by ADAMTS13 under fluid shear stress.","volume":"285","author":"Skipwith","year":"2010","journal-title":"J Biol Chem"},{"key":"R12-2-20210203","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.thromres.2009.08.020","article-title":"Flow-based measurements of von Willebrand factor (VWF) function: Binding to collagen and platelet adhesion under physiological shear rate.","volume":"125","author":"Fuchs","year":"2010","journal-title":"Thromb Res"},{"key":"R13-2-20210203","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1073\/pnas.0903679106","article-title":"Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor.","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R14-2-20210203","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.me.37.020186.001105","article-title":"von Willebrand factor and platelet function.","volume":"37","author":"Moroose","year":"1986","journal-title":"Annu Rev Med"},{"key":"R15-2-20210203","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor.","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"R16-2-20210203","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.cb.06.110190.001245","article-title":"Cell biology of von Willebrand factor.","volume":"6","author":"Wagner","year":"1990","journal-title":"Annu Rev Cell Biol"},{"key":"R17-2-20210203","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.blre.2005.02.002","article-title":"Oligosaccharide structures of von Willebrand factor and their potential role in von Willebrand disease.","volume":"20","author":"Millar","year":"2006","journal-title":"Blood Rev"},{"key":"R18-2-20210203","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1749-6632.1991.tb43700.x","article-title":"von Willebrand factor biosynthesis and processing.","volume":"614","author":"Mayadas","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"R19-2-20210203","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/324270a0","article-title":"Structure of prepro-von Willebrand factor and its expression in heterologous cells.","volume":"324","author":"Bonthron","year":"1986","journal-title":"Nature"},{"key":"R20-2-20210203","doi-asserted-by":"crossref","first-page":"49982","DOI":"10.1074\/jbc.M408727200","article-title":"A covalent oxidoreductase intermediate in propeptide-dependent von Willebrand factor multimerization.","volume":"279","author":"Purvis","year":"2004","journal-title":"J Biol Chem"},{"key":"R21-2-20210203","first-page":"224","article-title":"Biosynthesis of human von Willebrand factor.","volume":"18","author":"Verweij","year":"1988","journal-title":"Haemostasis"},{"key":"R22-2-20210203","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood.V92.8.2791","article-title":"Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo.","volume":"92","author":"Yamamoto","year":"1998","journal-title":"Blood"},{"key":"R23-2-20210203","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1073\/pnas.92.10.4567","article-title":"Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice.","volume":"92","author":"Aird","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R24-2-20210203","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-0037-1616933","article-title":"Mouse models to study von Willebrand factor structure-function relationships in vivo.","volume":"29","author":"Denis","year":"2009","journal-title":"Hamostaseologie"},{"key":"R25-2-20210203","doi-asserted-by":"crossref","first-page":"31704","DOI":"10.1074\/jbc.M109.030312","article-title":"Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival.","volume":"284","author":"Baudhuin","year":"2009","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"R26-2-20210203","doi-asserted-by":"crossref","first-page":"S294","DOI":"10.1016\/j.legalmed.2009.01.042","article-title":"Immunohistochemistry of von Willebrand factor in the lungs with regard to the cause of death in forensic autopsy.","volume":"11","author":"Quan","year":"2009","journal-title":"Leg Med (Tokyo)"},{"key":"R27-2-20210203","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1126\/science.1170905","article-title":"Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor.","volume":"324","author":"Zhang","year":"2009","journal-title":"Science"},{"key":"R28-2-20210203","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/j.1538-7836.2007.02737.x","article-title":"Requirements for cellular co-trafficking of factor VIII and von Willebrand factor to Weibel-Palade bodies.","volume":"5","author":"van den Biggelaar","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R29-2-20210203","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/ar295","article-title":"Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma).","volume":"3","author":"Scheja","year":"2001","journal-title":"Arthritis Res"},{"key":"R30-2-20210203","doi-asserted-by":"crossref","first-page":"7768","DOI":"10.1016\/S0021-9258(18)83104-0","article-title":"Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140.","volume":"264","author":"Hattori","year":"1989","journal-title":"J Biol Chem"},{"key":"R31-2-20210203","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/00007890-199311000-00032","article-title":"Cyclosporine and cremaphor modulate von Willebrand factor release from cultured human endothelial cells.","volume":"56","author":"Collins","year":"1993","journal-title":"Transplantation"},{"key":"R32-2-20210203","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2004-07-2698","article-title":"Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMP.","volume":"107","author":"Cleator","year":"2006","journal-title":"Blood"},{"key":"R33-2-20210203","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1055\/s-0038-1656135","article-title":"Epinephrine induces von Willebrand factor release from cultured endothelial cells: involvement of cyclic AMP-dependent signalling in exocytosis.","volume":"77","author":"Vischer","year":"1997","journal-title":"Thromb Haemost"},{"key":"R34-2-20210203","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1073\/pnas.92.7.2428","article-title":"Platelet von Willebrand factor in inherited and acquired bleeding disorders.","volume":"92","author":"Mannucci","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R35-2-20210203","first-page":"862","article-title":"Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays Thromb R","volume":"123","author":"Favaloro","year":"2009","journal-title":"es"},{"key":"R36-2-20210203","first-page":"926","article-title":"VWF secretion: whats in a name B","volume":"112","author":"Johnsen","year":"2008","journal-title":"lood"},{"key":"R37-2-20210203","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1182\/blood-2007-12-130740","article-title":"Basal secretion of von Willebrand factor from human endothelial cells.","volume":"112","author":"Giblin","year":"2008","journal-title":"Blood"},{"key":"R38-2-20210203","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1126\/science.3874428","article-title":"Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization.","volume":"228","author":"Ginsburg","year":"1985","journal-title":"Science"},{"key":"R39-2-20210203","doi-asserted-by":"crossref","first-page":"19514","DOI":"10.1016\/S0021-9258(19)47144-5","article-title":"Structure of the gene for human von Willebrand factor.","volume":"264","author":"Mancuso","year":"1989","journal-title":"J Biol Chem"},{"key":"R40-2-20210203","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1073\/pnas.84.13.4393","article-title":"Molecular cloning of the human gene for von Willebrand factor and identification of the transcription initiation site.","volume":"84","author":"Collins","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R41-2-20210203","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1096\/fasebj.7.2.8440408","article-title":"von Willebrand factor.","volume":"7","author":"Ruggeri","year":"1993","journal-title":"FASEB J"},{"key":"R42-2-20210203","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0092-8674(86)90735-X","article-title":"Inducible secretion of large, biologically potent von Willebrand factor multimers.","volume":"46","author":"Sporn","year":"1986","journal-title":"Cell"},{"key":"R43-2-20210203","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1091\/mbc.10.7.2149","article-title":"Assembly of a novel cartilage matrix protein filamentous network: molecular basis of differential requirement of von Willebrand factor A domains.","volume":"10","author":"Chen","year":"1999","journal-title":"Mol Biol Cell"},{"key":"R44-2-20210203","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1172\/JCI116112","article-title":"O-Linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein 1b.","volume":"90","author":"Carew","year":"1992","journal-title":"J Clin Invest"},{"key":"R45-2-20210203","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1182\/blood.V76.12.2530.2530","article-title":"Sulfation of von Willebrand factor.","volume":"76","author":"Carew","year":"1990","journal-title":"Blood"},{"key":"R46-2-20210203","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1182\/blood-2006-06-032706","article-title":"Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levels.","volume":"109","author":"van Schooten","year":"2007","journal-title":"Blood"},{"key":"R47-2-20210203","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood-2002-03-0789","article-title":"The role of the D1 domain of the von Willebrand factor propeptide in multimerization of VWF.","volume":"100","author":"Rosenberg","year":"2002","journal-title":"Blood"},{"key":"R48-2-20210203","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1538-7836.2003.00435.x","article-title":"Dimerization and multimerization defects of von Willebrand factor due to mutated cysteine residues.","volume":"2","author":"Tjernberg","year":"2004","journal-title":"J Thromb Haemost"},{"key":"R49-2-20210203","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1160\/TH06-01-0026","article-title":"Impaired dimerization of von Willebrand factor subunit due to mutation A2801D in the CK domain results in a recessive type 2A subtype IID von Willebrand disease.","volume":"95","author":"Hommais","year":"2006","journal-title":"Thromb Haemost"},{"key":"R50-2-20210203","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1016\/S0021-9258(17)37439-2","article-title":"Disulfide bonds required to assemble functional von Willebrand factor multimers.","volume":"269","author":"Dong","year":"1994","journal-title":"J Biol Chem"},{"key":"R51-2-20210203","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/j.1460-2075.1990.tb08176.x","article-title":"Domains involved in multimer assembly of von Willebrand factor (vWF): multimerization is independent of dimerization.","volume":"9","author":"Voorberg","year":"1990","journal-title":"EMBO J"},{"key":"R52-2-20210203","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1182\/blood.V84.4.1024.1024","article-title":"Characterization of von Willebrand factor gene defects in two unrelated patients with type IIC von Willebrand disease.","volume":"84","author":"Gaucher","year":"1994","journal-title":"Blood"},{"key":"R53-2-20210203","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1074\/jbc.M508316200","article-title":"ADAMTS13 substrate recognition of von Willebrand factor A2 domain.","volume":"281","author":"Zanardelli","year":"2006","journal-title":"J Biol Chem"},{"key":"R54-2-20210203","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1182\/blood-2009-05-224915","article-title":"A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF.","volume":"114","author":"Zanardelli","year":"2009","journal-title":"Blood"},{"key":"R55-2-20210203","doi-asserted-by":"crossref","first-page":"10396","DOI":"10.1074\/jbc.273.17.10396","article-title":"Crystal structure of the von Willebrand factor A1 domain and implications for the binding of platelet glycoprotein Ib.","volume":"273","author":"Emsley","year":"1998","journal-title":"J Biol Chem"},{"key":"R56-2-20210203","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/bcmd.1997.0128","article-title":"Crystal structure of NMC-4 fab antivon Willebrand factor A1 domain.","volume":"23","author":"Celikel","year":"1997","journal-title":"Blood Cells Mol Dis"},{"key":"R57-2-20210203","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nsb0398-189","article-title":"Crystal structure of the von Willebrand factor A1 domain in complex with the function blocking NMC-4 Fab.","volume":"5","author":"Celikel","year":"1998","journal-title":"Nat Struct Biol"},{"key":"R58-2-20210203","doi-asserted-by":"crossref","first-page":"19098","DOI":"10.1074\/jbc.M002292200","article-title":"Mapping the glycoprotein Ib-binding site in the von Willebrand factor A1 domain.","volume":"275","author":"Cruz","year":"2000","journal-title":"J Biol Chem"},{"key":"R59-2-20210203","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1126\/science.107355","article-title":"Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain.","volume":"297","author":"Huizinga","year":"2002","journal-title":"Science"},{"key":"R60-2-20210203","doi-asserted-by":"crossref","first-page":"37777","DOI":"10.1074\/jbc.M305566200","article-title":"Crystal structure of von Willebrand factor A1 domain complexed with snake venom, bitiscetin: insight into glycoprotein Ibalpha binding mechanism induced by snake venom proteins.","volume":"278","author":"Maita","year":"2003","journal-title":"J Biol Chem"},{"key":"R61-2-20210203","doi-asserted-by":"crossref","first-page":"25162","DOI":"10.1074\/jbc.272.40.25162","article-title":"The von Willebrand factor A3 domain does not contain a metal ion-dependent adhesion site motif.","volume":"272","author":"Bienkowska","year":"1997","journal-title":"J Biol Chem"},{"key":"R62-2-20210203","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1073\/pnas.89.8.3531","article-title":"Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly.","volume":"89","author":"Mayadas","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R63-2-20210203","doi-asserted-by":"crossref","first-page":"13406","DOI":"10.1074\/jbc.270.22.13406","article-title":"Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor.","volume":"270","author":"Matsushita","year":"1995","journal-title":"J Biol Chem"},{"key":"R64-2-20210203","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1073\/pnas.0401506101","article-title":"Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor.","volume":"101","author":"Lacy","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R65-2-20210203","doi-asserted-by":"crossref","first-page":"13592","DOI":"10.1021\/bi0114933","article-title":"Crystal structure of bitiscetin, a von Willebrand factor-dependent platelet aggregation inducer.","volume":"40","author":"Hirotsu","year":"2001","journal-title":"Biochemistry"},{"key":"R66-2-20210203","doi-asserted-by":"crossref","first-page":"19099","DOI":"10.1073\/pnas.0607264104","article-title":"Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease.","volume":"103","author":"Gao","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R67-2-20210203","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0969-2126(97)00266-9","article-title":"Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding.","volume":"5","author":"Huizinga","year":"1997","journal-title":"Structure"},{"key":"R68-2-20210203","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1023\/A:1021669129988","article-title":"Backbone 1H, 13C, and 15N resonance assignments of the von Willebrand factor A3 domain.","volume":"24","author":"Nishida","year":"2002","journal-title":"J Biomol NMR"},{"key":"R69-2-20210203","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1182\/blood-2008-10-184317","article-title":"Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor.","volume":"114","author":"Riddell","year":"2009","journal-title":"Blood"},{"key":"R70-2-20210203","doi-asserted-by":"crossref","first-page":"15035","DOI":"10.1074\/jbc.M208977200","article-title":"Mapping the collagen-binding site in the von Willebrand factor-A3 domain.","volume":"278","author":"Romijn","year":"2003","journal-title":"J Biol Chem"},{"key":"R71-2-20210203","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s000180050115","article-title":"Biochemical and functional characterization of recombinant von Willebrand factor produced on a large scale.","volume":"53","author":"Fischer","year":"1997","journal-title":"Cell Mol Life Sci"},{"key":"R72-2-20210203","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1016-8478(23)10764-3","article-title":"Long-term expression of von Willebrand Factor by a VSV-G pseudotyped lentivirus enhances the functional activity of secreted B-Domain-deleted Coagulation Factor VIII.","volume":"24","author":"Park","year":"2007","journal-title":"Mol Cells"},{"key":"R73-2-20210203","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/10408360600966753","article-title":"The role of von Willebrand factor in hemorrhagic and thrombotic disorders.","volume":"44","author":"Franchini","year":"2007","journal-title":"Crit Rev Clin Lab Sci"},{"key":"R74-2-20210203","doi-asserted-by":"crossref","first-page":"D561","DOI":"10.1093\/nar\/gkq973","article-title":"The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored.","volume":"39","author":"Szklarczyk","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"R75-2-20210203","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1126\/science.1075452","article-title":"Biomedicine. Contact - how platelets touch von Willebrand factor.","volume":"297","author":"Sadler","year":"2002","journal-title":"Science"},{"key":"R76-2-20210203","first-page":"H1208","article-title":"Platelet-collagen adhesion enhances platelet aggregation induced by binding of VWF to platelets.","volume":"253","author":"Laduca","year":"1987","journal-title":"Am J Physiol"},{"key":"R77-2-20210203","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1055\/s-0037-1614609","article-title":"Recombinant vWF type 2A mutants R834Q and R834W show a defect in mediating platelet adhesion to collagen, independent of enhanced sensitivity to a plasma protease.","volume":"81","author":"Lankhof","year":"1999","journal-title":"Thromb Haemost"},{"key":"R78-2-20210203","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1083\/jcb.109.1.367","article-title":"Von Willebrand factor promotes endothelial cell adhesion via an Arg-Gly-Asp-dependent mechanism.","volume":"109","author":"Dejana","year":"1989","journal-title":"J Cell Biol"},{"key":"R79-2-20210203","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0025-6196(12)61204-X","article-title":"Structure and function of von Willebrand factor: relationship to von Willebrands disease.","volume":"66","author":"Ruggeri","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"R80-2-20210203","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1538-7836.2006.01742.x","article-title":"The interaction of von Willebrand factor-A1 domain with collagen: mutation G1324S (type 2M von Willebrand disease) impairs the conformational change in A1 domain induced by collagen.","volume":"4","author":"Morales","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R81-2-20210203","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.thromres.2006.06.010","article-title":"Surface-dependent expression in the platelet GPIb binding domain within human von Willebrand factor studied by atomic force microscopy.","volume":"119","author":"Kang","year":"2007","journal-title":"Thromb Res"},{"key":"R82-2-20210203","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1182\/blood-2010-02-269266","article-title":"Von Willebrand Factor self-association on platelet GpIbalpha under hydrodynamic shear: effect on shear-induced platelet activation.","volume":"116","author":"Dayananda","year":"2010","journal-title":"Blood"},{"key":"R83-2-20210203","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1586\/14779072.1.2.257","article-title":"Inhibition of von Willebrand factor-GPIbIXV interactions as a strategy to prevent arterial thrombosis.","volume":"1","author":"Bonnefoy","year":"2003","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R84-2-20210203","doi-asserted-by":"crossref","first-page":"16285","DOI":"10.1074\/jbc.M307230200","article-title":"Identification of the amino acid residues of the platelet glycoprotein Ib (GPIb) essential for the von Willebrand factor binding by clustered charged-to-alanine scanning mutagenesis.","volume":"279","author":"Shimizu","year":"2004","journal-title":"J Biol Chem"},{"key":"R85-2-20210203","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0021-9258(17)35234-1","article-title":"Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor.","volume":"266","author":"Leyte","year":"1991","journal-title":"J Biol Chem"},{"key":"R86-2-20210203","doi-asserted-by":"crossref","first-page":"8149","DOI":"10.1016\/S0021-9258(18)92954-6","article-title":"Dimeric ristocetin flocculates proteins, binds to platelets, and mediates von Willebrand factor-dependent agglutination of platelets.","volume":"266","author":"Scott","year":"1991","journal-title":"J Biol Chem"},{"key":"R87-2-20210203","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/09537101003695339","article-title":"2nd, et al. GPIbalpha-selective activation of platelets induces platelet signaling events comparable to GPVI activation events.","volume":"21","author":"Gardiner","year":"2010","journal-title":"Platelets"},{"key":"R88-2-20210203","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1182\/blood-2002-06-1879","article-title":"Activation of pp125FAK by type 2B recombinant von Willebrand factor binding to platelet GPIb at a high shear rate occurs independently of alpha IIb beta 3 engagement.","volume":"101","author":"Mekrache","year":"2003","journal-title":"Blood"},{"key":"R89-2-20210203","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1182\/blood-2010-05-287623","article-title":"von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models.","volume":"117","author":"Brill","year":"2011","journal-title":"Blood"},{"key":"R90-2-20210203","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0968-0004(91)90096-E","article-title":"Arginyl-glycyl-aspartic acid (RGD): a cell adhesion motif.","volume":"16","author":"DSouza","year":"1991","journal-title":"Trends Biochem Sci"},{"key":"R91-2-20210203","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1111\/j.1538-7836.2005.01534.x","article-title":"Association of the antagonism of von Willebrand factor but not fibrinogen by platelet alphaIIbbeta3 antagonists with prolongation of bleeding time.","volume":"3","author":"Aoki","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R92-2-20210203","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1161\/01.ATV.17.11.3202","article-title":"Shear-stress-induced detachment of blood platelets from various surfaces.","volume":"17","author":"Wu","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R93-2-20210203","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bpj.2009.05.009","article-title":"Changes in thermodynamic stability of von Willebrand factor differentially affect the force-dependent binding to platelet GPIbalpha.","volume":"97","author":"Auton","year":"2009","journal-title":"Biophys J"},{"key":"R94-2-20210203","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.3324\/haematol.12830","article-title":"Novel point mutation in a leucine-rich repeat of the GPIbalpha chain of the platelet von Willebrand factor receptor, GPIbIXV, resulting in an inherited dominant form of Bernard-Soulier syndrome affecting two unrelated families: the N41H variant.","volume":"93","author":"Vettore","year":"2008","journal-title":"Haematologica"},{"key":"R95-2-20210203","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood-2003-07-2267","article-title":"von Willebrand factor C1C2 domain is involved in platelet adhesion to polymerized fibrin at high shear rate.","volume":"103","author":"Keuren","year":"2004","journal-title":"Blood"},{"key":"R96-2-20210203","doi-asserted-by":"crossref","first-page":"16900","DOI":"10.1073\/pnas.0608207103","article-title":"The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis.","volume":"103","author":"Bergmeier","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R97-2-20210203","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1016\/S0021-9258(18)47430-3","article-title":"A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor.","volume":"262","author":"Foster","year":"1987","journal-title":"J Biol Chem"},{"key":"R98-2-20210203","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1042\/bj2570679","article-title":"The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII.","volume":"257","author":"Leyte","year":"1989","journal-title":"Biochem J"},{"key":"R99-2-20210203","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1365-2141.2003.04163.x","article-title":"Two novel mutations, Q1053H and C1060R, located in the D3 domain of von Willebrand factor, are responsible for decreased FVIII-binding capacity.","volume":"120","author":"Hilbert","year":"2003","journal-title":"Br J Haematol"},{"key":"R100-2-20210203","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1016\/S0021-9258(17)35782-4","article-title":"von Willebrand factor binds specifically to sulfated glycolipids.","volume":"261","author":"Roberts","year":"1986","journal-title":"J Biol Chem"},{"key":"R101-2-20210203","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1046\/j.1538-7836.2003.00156.x","article-title":"Sulfatides inhibit platelet adhesion to von Willebrand factor in flowing blood.","volume":"1","author":"Borthakur","year":"2003","journal-title":"J Thromb Haemost"},{"key":"R102-2-20210203","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood.V78.9.2310.2310","article-title":"The binding domain of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin, and collagen and resides between amino acid residues Leu 512 and Lys 673.","volume":"78","author":"Christophe","year":"1991","journal-title":"Blood"},{"key":"R103-2-20210203","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s12185-008-0065-8","article-title":"Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis.","volume":"87","author":"Nakayama","year":"2008","journal-title":"Int J Hematol"},{"key":"R104-2-20210203","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1172\/JCI115198","article-title":"Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo.","volume":"87","author":"Sobel","year":"1991","journal-title":"J Clin Invest"},{"key":"R105-2-20210203","doi-asserted-by":"crossref","first-page":"8857","DOI":"10.1016\/S0021-9258(19)50359-3","article-title":"Localization and characterization of a heparin binding domain peptide of human von Willebrand factor.","volume":"267","author":"Sobel","year":"1992","journal-title":"J Biol Chem"},{"key":"R106-2-20210203","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrands disease.","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"R107-2-20210203","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1182\/blood.V79.10.2507.bloodjournal79102507","article-title":"Molecular genetics of von Willebrand disease.","volume":"79","author":"Ginsburg","year":"1992","journal-title":"Blood"},{"key":"R108-2-20210203","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-2516.2008.01966.x","article-title":"Contribution of genetical analysis for diagnosis of von Willebrands disease type 2B.","volume":"15","author":"Victor","year":"2009","journal-title":"Haemophilia"},{"key":"R110-2-20210203","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3324\/haematol.11460","article-title":"Thrombin-generating capacity in patients with von Willebrands disease.","volume":"92","author":"Rugeri","year":"2007","journal-title":"Haematologica"},{"key":"R111-2-20210203","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1182\/blood-2005-06-2330","article-title":"Correction of a murine model of von Willebrand disease by gene transfer.","volume":"108","author":"Pergolizzi","year":"2006","journal-title":"Blood"},{"key":"R112-2-20210203","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/1076029606293422","article-title":"Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease.","volume":"12","author":"Michiels","year":"2006","journal-title":"Clin Appl Thromb Hemost"},{"key":"R113-2-20210203","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2010.03.003","article-title":"The genetic basis of von Willebrand disease.","volume":"24","author":"Goodeve","year":"2010","journal-title":"Blood Rev"},{"key":"R114-2-20210203","first-page":"112","article-title":"Low von Willebrand factor: sometimes a risk factor and sometimes a disease.","volume":"106-","author":"Sadler","year":"2009","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"R115-2-20210203","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood-2007-09-110940","article-title":"Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).","volume":"111","author":"Haberichter","year":"2008","journal-title":"Blood"},{"key":"R116-2-20210203","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1182\/blood-2009-12-261131","article-title":"Functional characterization of a 13bp deletion (c.-1522-1510del13) in the promoter of the von Willebrand factor gene in type 1 von Willebrand disease.","volume":"116","author":"Othman","year":"2010","journal-title":"Blood"},{"key":"R117-2-20210203","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajh.20372","article-title":"von Willebrands disease and menorrhagia: prevalence, diagnosis, and management.","volume":"79","author":"Kujovich","year":"2005","journal-title":"Am J Hematol"},{"key":"R118-2-20210203","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3324\/haematol.2009.019927","article-title":"Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia.","volume":"95","author":"Casonato","year":"2010","journal-title":"Haematologica"},{"key":"R119-2-20210203","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2516.2006.01393.x","article-title":"The 80th anniversary of von Willebrands disease: history, management and research.","volume":"12","author":"Federici","year":"2006","journal-title":"Haemophilia"},{"key":"R120-2-20210203","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1046\/j.1365-2141.1998.01064.x","article-title":"Two novel mutations (Pro864His, Val867Glu) causing type 2A von Willebrand disease and affecting a single restriction site in exon 28.","volume":"103","author":"Bernardi","year":"1998","journal-title":"Br J Haematol"},{"key":"R121-2-20210203","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198005083021902","article-title":"Heightened interaction between platelets and factor VIIIvon Willebrand factor in a new subtype of von Willebrands disease.","volume":"302","author":"Ruggeri","year":"1980","journal-title":"N Engl J Med"},{"key":"R122-2-20210203","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1182\/blood-2008-06-165233","article-title":"The Montreal platelet syndrome kindred has type 2B von Willebrand disease with the VWF V1316 M mutation.","volume":"113","author":"Jackson","year":"2009","journal-title":"Blood"},{"key":"R123-2-20210203","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood-2008-04-152280","article-title":"Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients.","volume":"113","author":"Federici","year":"2009","journal-title":"Blood"},{"key":"R124-2-20210203","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000214854","article-title":"Autosomal dominant von Willebrand disease type 2 M.","volume":"121","author":"Hermans","year":"2009","journal-title":"Acta Haematol"},{"key":"R125-2-20210203","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/blood.V91.5.1572","article-title":"Type 2 M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin - but not botrocetin-mediated binding of von Willebrand factor to platelets.","volume":"91","author":"Hillery","year":"1998","journal-title":"Blood"},{"key":"R126-2-20210203","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1182\/blood.V95.6.2000","article-title":"Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor.","volume":"95","author":"Allen","year":"2000","journal-title":"Blood"},{"key":"R127-2-20210203","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/beha.2001.0138","article-title":"Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology.","volume":"14","author":"Mazurier","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"R128-2-20210203","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/j.1538-7836.2006.02070.x","article-title":"Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study.","volume":"4","author":"Castaman","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"Suppl 4","key":"R129-2-20210203","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2516.2004.00991.x","article-title":"Clinical diagnosis of von Willebrand disease.","volume":"10","author":"Federici","year":"2004","journal-title":"Haemophilia"},{"key":"R130-2-20210203","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000275926","article-title":"Platelet-type von Willebrand disease: results of a worldwide survey from the Canadian PT-VWD project.","volume":"123","author":"Othman","year":"2010","journal-title":"Acta Haematol"},{"key":"R131-2-20210203","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2141.2007.06850.x","article-title":"Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysis.","volume":"139","author":"Favaloro","year":"2007","journal-title":"Br J Haematol"},{"key":"R132-2-20210203","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1182\/blood-2002-09-2942","article-title":"Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand disease.","volume":"105","author":"Othman","year":"2005","journal-title":"Blood"},{"key":"R133-2-20210203","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1172\/JCI116438","article-title":"Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant glycoprotein Ib alpha fragment.","volume":"91","author":"Murata","year":"1993","journal-title":"J Clin Invest"},{"key":"R134-2-20210203","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-2002-27817","article-title":"Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.","volume":"28","author":"Turecek","year":"2002","journal-title":"Semin Thromb Hemost"},{"key":"R135-2-20210203","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1538-7836.2008.02845.x","article-title":"A highly-sensitive plasma von Willebrand factor ristocetin cofactor (VWF:RCo) activity assay by flow cytometry.","volume":"6","author":"Chen","year":"2008","journal-title":"J Thromb Haemost"},{"key":"R136-2-20210203","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-2007-1000364","article-title":"An update on the von Willebrand factor collagen binding assay: 21 years of age and beyond adolescence but not yet a mature adult.","volume":"33","author":"Favaloro","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"R137-2-20210203","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1111\/j.1538-7836.2006.02069.x","article-title":"von Willebrand factor collagen binding assay in von Willebrand disease type 2A, 2B, and 2M.","volume":"4","author":"Baronciani","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R138-2-20210203","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1254\/jphs.08147SC","article-title":"A new binding assay of von Willebrand factor and glycoprotein Ib using solid-phase biotinylated platelets.","volume":"108","author":"Hayata","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"R139-2-20210203","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2516.2009.01995.x","article-title":"Measurement of von Willebrand factor-FVIII binding activity in patients with suspected von Willebrand disease type 2N: application of an ELISA-based assay in a reference laboratory.","volume":"15","author":"Zhukov","year":"2009","journal-title":"Haemophilia"},{"key":"R140-2-20210203","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1111\/j.1538-7836.2010.04029.x","article-title":"Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol.","volume":"8","author":"Hillarp","year":"2010","journal-title":"J Thromb Haemost"},{"key":"R141-2-20210203","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1111\/j.1538-7836.2010.04123.x","article-title":"Validation of improved performance characteristics for the automated von Willebrand factor ristocetin cofactor activity assay.","volume":"8","author":"Favaloro","year":"2010","journal-title":"J Thromb Haemost"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MBC.0b013e32834cb35d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:31:16Z","timestamp":1786048276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-201201000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":139,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e32834cb35d","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}